Cohen Neil Harris

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 12% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -78%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Cohen Neil Harris's trades of Chemomab Therapeutics Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
105.40
Quantity 60,342 -18.9%
Value US$1,024,499
Transaction date
Sale
Price
173.07
Quantity 71,989 -6.9%
Value US$3,301,394
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-01 2026-08-28
S Sale
60,342 -18.9%
105.40
US$1,024,499 		60,342 -18.9% 105.40 US$1,024,499
2026-09-01 2026-08-27
S Sale
71,989 -6.9%
173.07
US$3,301,394 		71,989 -6.9% 173.07 US$3,301,394
2022-11-18 2022-11-16
S Sale
73,037 +6.2%
478.06
US$976,906 		73,037 +6.2% 478.06 US$976,906
2022-05-19 2022-05-18
B Purchase
2,000 +19.2%
3.19
US$6,380 		2,000 +19.2% 3.19 US$6,380
2022-03-15 2022-03-14
B Purchase
2,000 +23.8%
4.56
US$9,120 		2,000 +23.8% 4.56 US$9,120
2022-03-15 2022-03-14
B Purchase
2,000 +31.2%
4.30
US$8,600 		2,000 +31.2% 4.30 US$8,600
2022-03-15 2022-03-14
B Purchase
2,000 +45.4%
4.20
US$8,400 		2,000 +45.4% 4.20 US$8,400
2021-12-08 2021-12-06
B Purchase
2,000 +83.0%
7.43
US$14,860 		2,000 +83.0% 7.43 US$14,860
2021-03-26 2021-03-16
B Purchase
2,409 +inf%
41.51
US$99,998 		2,409 +inf% 41.51 US$99,998